Results 81 to 90 of about 75,748 (340)
Biomarkers of lung congestion and injury in acute heart failure
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi +9 more
wiley +1 more source
冠心病患者NT-ProBNP与HS-CRP联合检测的临床意义
目的探讨冠心病患者中NT-proBNP与hs-CRP联合检测的临床意义。方法收集临床上冠心病患者并进行分组,其中AMI组25例,UA组20例,SA组25例;正常对照组10例,所有患者入院后均即刻进行NT-proBNP与hs-CRP的检测,并根据NT-proBNP与hs-CRP高低再进一步将所有患者分成低NT-proBNP/低hs-CRP;低NT-proBNP/高hs-CRP;高NT-proBNP/低hs-CRP;高NT-proBNP/高hs-CRP四组。结果高NT-proBNP/高hs ...
宋春莉, 刘斌, 费瑜, 陈宏勃
doaj
N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea [PDF]
The obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular abnormalities including left ventricular hypertrophy, left ventricular diastolic dysfunction, and endothelial dysfunction.
Ammann, Peter +7 more
core
MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio +10 more
wiley +1 more source
Background Up to 20% of COVID-19 patients can suffer COVID-19-related myocardial injury. Elevated cardiac biomarkers, such as hs-cTnT and NT-proBNP, have been related to worse short-term prognosis.
Diana Mojón-Álvarez +9 more
doaj +1 more source
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood [PDF]
Background: The Roche CARDIAC proBNP point-of-care (POC) test is the first test intended for the quantitative determination of N-terminal pro-brain natriuretic peptide (NT-proBNP) in whole blood as an aid in the diagnosis of suspected congestive heart ...
Collinson, Paul O. +16 more
core
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi +4 more
wiley +1 more source
ST2 and Multimarker Testing in Acute Decompensated Heart Failure [PDF]
Most data on heart failure biomarkers have been derived from patient cohorts with chronic disease. However, risk prediction in patients admitted with acute decompensated heart failure (ADHF) remains a challenge.
Antoni, Md +7 more
core +1 more source
Sendaway capillary NT-proBNP in pulmonary hypertension
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to perform NT-proBNP tests remotely.
Harrison D Stubbs +14 more
openaire +4 more sources

